QIAGEN Introduces Novel Technology for Customized RNAi Assay Products
13th Nov 2006, 17:29 GMT
Worldwide 1st Solution for Flexible siRNA Selection Provides New Dimension of Utility and Performance in one of Life Sciences' Most Promising Disciplines QIAGEN, the world's leading provider of products for pre-analytical sample preparation and a leader in molecular diagnostics, has introduced FlexiPlate siRNA, the worldwide 1st product line for fully customized sets of siRNAs for RNA Interference research.
QIAGEN Introduces Novel Technology for Customized RNAi Assay Products related news:
- Qiagen N.V.: QIAGEN Introduces Novel Technology for Customized RNAi Assay Products — Market Wire - Pharmaceuticals and Biotech
- QIAGEN Introduces Novel Technology for Customized RNAi Assay Products — PR Newswire: All Releases
- Google introduces customized home pages for groups (Reuters) — Yahoo! News: Technology News
- Tabelle: Qiagen NV - 3. Quartal 2006 — Finanztreff.de / BRANCHEN
- Keithley Introduces PXI Products for Hybrid Test Systems in Production Applications — StratWire - Business of Healthcare NewsFeed
- SCOLR Pharma Partner Introduces 3 New Products Based on SCOLR Technology — Operations-Related News from StratCenter.com
- New Archive Attender® V 3.0 Takes Aim at Efficiency by Offering a Rapid, 15-Minute Installation — PR Leap - Technology News Releases
- QIAGEN-Zahlen treffen Erwartungen — Nachrichten Ticker - www.finanzen.net
- Qiagen erfüllt im 3Q eigene Prognose - Einmaleffekte belasten — Finanztreff.de / BRANCHEN
- Google introduces customized home pages for groups — Reuters: Internet
Latest news from Laboratory News from StratCenter.com:
- Abstract Evaluating QUADRAMET for Multiple Myeloma Presented erican Society of Hematology Annual Meeting
- Stratagene Reports Q3 Results
- Viking Systems Appoints Dr Michael Manyak to Its Board
- Soliant Health To Exhibit at the American Speech-Language-Hearing Assoc Conference
- Sysmex America Awarded Contract to Service VA Med Cntrs in Midwest States
- Ronald D Luff, MD, Recognized By the American Society of Cytopathology for Groundbreaking Work in Diagnosis of Cervical Disease
- INNOVIVE Pharmaceuticals Reports Q3 Results
- Launch of 'Egg Banking' Program Breaks New Ground as 1st Program of Its Kind in NC
- Global Care Quest Announces ICIS 5
- Portola Pharmaceuticals Presents Data Associated With Its Novel Anticoagulation Assay at American Heart Assoc Scientific Sessions